Fractyl Health (GUTS) Liabilities and Shareholders Equity (2023 - 2026)

Fractyl Health (GUTS) has 4 years of Liabilities and Shareholders Equity data on file, last reported at $99.4 million in Q1 2026.

• Quarterly Liabilities and Shareholders Equity rose 19.68% year-over-year to $99.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $397.1 million (down 14.51% YoY) and the FY2025 annual result came in at $121.4 million, up 12.33% from the prior year.
• Liabilities and Shareholders Equity declined to $99.4 million in Q1 2026, from $121.4 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $163.5 million in Q1 2024 to a low of $62.0 million in Q2 2025.
• A 4-year average of $110.1 million and a median of $111.2 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
• Annual changes were most pronounced in 2024 — Liabilities and Shareholders Equity surged 41.81% — and 2025, when it sank 57.66%.
• Tracing GUTS's Liabilities and Shareholders Equity over 4 years: stood at $76.2 million in 2023, then surged by 41.81% to $108.1 million in 2024, then grew by 12.33% to $121.4 million in 2025, then declined by 18.14% to $99.4 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $99.4 million (Q1 2026), $121.4 million (Q4 2025), and $114.3 million (Q3 2025), per Business Quant data.